1. Home
  2. NPK vs AKBA Comparison

NPK vs AKBA Comparison

Compare NPK & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPK
  • AKBA
  • Stock Information
  • Founded
  • NPK 1905
  • AKBA 2007
  • Country
  • NPK United States
  • AKBA United States
  • Employees
  • NPK N/A
  • AKBA N/A
  • Industry
  • NPK Ordnance And Accessories
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NPK Industrials
  • AKBA Health Care
  • Exchange
  • NPK Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • NPK 786.1M
  • AKBA 729.1M
  • IPO Year
  • NPK N/A
  • AKBA 2014
  • Fundamental
  • Price
  • NPK $94.26
  • AKBA $1.60
  • Analyst Decision
  • NPK
  • AKBA Strong Buy
  • Analyst Count
  • NPK 0
  • AKBA 6
  • Target Price
  • NPK N/A
  • AKBA $6.25
  • AVG Volume (30 Days)
  • NPK 66.1K
  • AKBA 5.5M
  • Earning Date
  • NPK 10-27-2025
  • AKBA 11-10-2025
  • Dividend Yield
  • NPK 1.06%
  • AKBA N/A
  • EPS Growth
  • NPK 14.20
  • AKBA N/A
  • EPS
  • NPK 5.43
  • AKBA N/A
  • Revenue
  • NPK $474,243,000.00
  • AKBA $225,071,000.00
  • Revenue This Year
  • NPK N/A
  • AKBA $53.38
  • Revenue Next Year
  • NPK N/A
  • AKBA $30.53
  • P/E Ratio
  • NPK $17.38
  • AKBA N/A
  • Revenue Growth
  • NPK 34.75
  • AKBA 32.49
  • 52 Week Low
  • NPK $77.63
  • AKBA $1.49
  • 52 Week High
  • NPK $120.49
  • AKBA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • NPK 33.78
  • AKBA 32.12
  • Support Level
  • NPK $93.22
  • AKBA $1.49
  • Resistance Level
  • NPK $95.53
  • AKBA $1.65
  • Average True Range (ATR)
  • NPK 3.20
  • AKBA 0.12
  • MACD
  • NPK -0.12
  • AKBA 0.01
  • Stochastic Oscillator
  • NPK 10.24
  • AKBA 18.10

About NPK National Presto Industries Inc.

National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments namely Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: